Kalvista Pharmaceuticals Inc banner

Kalvista Pharmaceuticals Inc
NASDAQ:KALV

Watchlist Manager
Kalvista Pharmaceuticals Inc Logo
Kalvista Pharmaceuticals Inc
NASDAQ:KALV
Watchlist
Price: 18.595 USD 8.49%
Market Cap: $940m

Cash Flow Statement

Cash Flow Statement
Kalvista Pharmaceuticals Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Jan-2017 Apr-2017 Jul-2017 Oct-2017 Jan-2018 Apr-2018 Jul-2018 Oct-2018 Jan-2019 Apr-2019 Jul-2019 Oct-2019 Jan-2020 Apr-2020 Jul-2020 Oct-2020 Jan-2021 Apr-2021 Jul-2021 Oct-2021 Jan-2022 Apr-2022 Jul-2022 Oct-2022 Jan-2023 Apr-2023 Jul-2023 Oct-2023 Jan-2024 Apr-2024 Jul-2024 Oct-2024 Jan-2025 Apr-2025 Jul-2025 Sep-2025
Operating Cash Flow
Net Income
(8)
(8)
(10)
(13)
(17)
(23)
(24)
(25)
(26)
(25)
(22)
(14)
(19)
(10)
(12)
(19)
(16)
(16)
(14)
(13)
(21)
(23)
(26)
(31)
(29)
(33)
(37)
(38)
(46)
(52)
(61)
(73)
(82)
(89)
(92)
(91)
(93)
(95)
(101)
(108)
(127)
(142)
(156)
(176)
(183)
(203)
(260)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Stock-Based Compensation
0
0
0
0
0
0
1
1
1
1
1
0
0
1
1
1
1
1
2
2
3
4
4
4
4
5
5
5
7
9
10
12
11
11
11
10
10
11
11
12
22
22
21
21
12
15
0
Other Non-Cash Items
1
1
1
1
2
5
5
4
6
3
3
(1)
(1)
(3)
(3)
1
0
1
1
2
3
4
4
4
4
4
4
4
7
10
12
16
16
16
14
11
10
9
11
11
21
21
19
27
15
22
27
Cash Interest Paid
0
0
1
1
1
1
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
1
1
1
1
1
(0)
(1)
(1)
(2)
(1)
0
(5)
(4)
(4)
(7)
33
26
24
20
(21)
(19)
(23)
(19)
(16)
(21)
(9)
(5)
1
8
(3)
(8)
(5)
(12)
(10)
(7)
(1)
7
7
11
(0)
15
17
13
20
15
13
32
Cash from Operating Activities
(7)
N/A
(6)
+9%
(8)
-32%
(11)
-42%
(14)
-20%
(18)
-33%
(20)
-12%
(21)
-4%
(22)
-5%
(23)
-4%
(19)
+16%
(21)
-11%
(24)
-13%
(16)
+33%
(21)
-36%
14
N/A
11
-24%
9
-17%
7
-17%
(32)
N/A
(36)
-14%
(41)
-14%
(40)
+2%
(43)
-6%
(45)
-5%
(37)
+17%
(37)
0%
(32)
+15%
(30)
+5%
(44)
-47%
(56)
-26%
(62)
-12%
(78)
-25%
(83)
-6%
(84)
-1%
(79)
+6%
(75)
+5%
(79)
-5%
(78)
+1%
(97)
-23%
(89)
+8%
(103)
-15%
(123)
-19%
(128)
-4%
(153)
-20%
(167)
-9%
(200)
-20%
Investing Cash Flow
Capital Expenditures
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(1)
(0)
(0)
0
0
(0)
(1)
(2)
(2)
(2)
(1)
(1)
(1)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(1)
(1)
(3)
Other Items
0
0
0
0
0
0
0
(1)
0
(1)
(1)
34
34
0
0
0
0
0
0
(55)
(68)
(70)
(71)
(7)
17
24
32
29
(148)
(138)
(126)
(120)
59
75
77
61
43
31
40
36
(84)
(67)
(47)
(31)
92
76
28
Cash from Investing Activities
(0)
N/A
(0)
-350%
(0)
+11%
(0)
-100%
(0)
-113%
(0)
N/A
(0)
-6%
(1)
-281%
(1)
N/A
(1)
+15%
(1)
+2%
34
N/A
34
N/A
34
0%
34
0%
(0)
N/A
(1)
-321%
(2)
-32%
(2)
-9%
(56)
-2 641%
(69)
-23%
(70)
-1%
(72)
-2%
(7)
+90%
17
N/A
24
+42%
32
+33%
29
-9%
(148)
N/A
(138)
+6%
(127)
+8%
(121)
+5%
58
N/A
73
+26%
75
+3%
60
-20%
41
-31%
31
-25%
39
+27%
35
-11%
(85)
N/A
(67)
+21%
(47)
+30%
(32)
+32%
91
N/A
75
-17%
25
-67%
Financing Cash Flow
Net Issuance of Common Stock
6
0
0
0
0
68
68
68
68
(0)
0
0
0
0
9
9
9
14
88
88
88
95
12
12
12
0
0
2
212
213
213
212
2
1
1
58
58
58
58
1
151
154
154
210
62
60
62
Net Issuance of Debt
2
1
7
7
9
10
4
4
0
(5)
(5)
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
97
100
122
261
Other
0
(0)
(0)
(1)
(2)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(2)
(2)
0
0
Cash from Financing Activities
8
N/A
1
-85%
7
+456%
6
-16%
8
+41%
77
+883%
71
-7%
72
+1%
69
-5%
(5)
N/A
(4)
+4%
0
N/A
0
N/A
5
N/A
14
+201%
9
-34%
9
0%
14
+55%
88
+529%
88
+0%
88
+0%
94
+7%
12
-88%
12
0%
12
-1%
0
-98%
0
-35%
2
+1 107%
212
+11 619%
213
+0%
213
N/A
212
0%
2
-99%
1
-28%
1
+10%
58
+4 563%
58
0%
58
+0%
58
0%
1
-99%
151
+25 619%
154
+2%
154
+0%
305
+99%
160
-48%
180
+13%
321
+78%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
0
(1)
(1)
(1)
(1)
3
2
1
0
(2)
(1)
(1)
1
1
0
1
(0)
0
1
0
1
(0)
(1)
(2)
(0)
1
1
2
0
(1)
(1)
(1)
(0)
(1)
3
5
6
Net Change in Cash
1
N/A
(5)
N/A
(1)
+70%
(6)
-300%
(6)
-4%
58
N/A
51
-13%
50
-1%
45
-9%
(29)
N/A
(25)
+14%
12
N/A
9
-22%
22
+135%
25
+15%
25
+1%
20
-20%
22
+8%
93
+330%
(2)
N/A
(19)
-718%
(18)
+6%
(99)
-453%
(38)
+62%
(16)
+57%
(12)
+25%
(6)
+54%
(1)
+84%
35
N/A
30
-13%
30
0%
28
-8%
(20)
N/A
(10)
+47%
(8)
+25%
39
N/A
26
-35%
12
-55%
19
+65%
(62)
N/A
(24)
+61%
(18)
+28%
(16)
+8%
145
N/A
100
-31%
93
-7%
152
+63%
Free Cash Flow
Free Cash Flow
(7)
N/A
(6)
+8%
(8)
-31%
(11)
-42%
(14)
-22%
(18)
-32%
(20)
-11%
(22)
-5%
(23)
-5%
(23)
-4%
(20)
+16%
(21)
-8%
(24)
-12%
(16)
+34%
(21)
-36%
14
N/A
9
-33%
7
-24%
5
-25%
(34)
N/A
(37)
-11%
(42)
-12%
(41)
+3%
(43)
-5%
(45)
-4%
(37)
+17%
(37)
0%
(32)
+15%
(30)
+5%
(45)
-48%
(57)
-27%
(63)
-12%
(79)
-25%
(85)
-7%
(86)
-1%
(81)
+6%
(76)
+5%
(80)
-4%
(79)
+1%
(97)
-23%
(90)
+8%
(103)
-15%
(123)
-19%
(128)
-4%
(154)
-20%
(168)
-10%
(203)
-20%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett